Physician profile
Arsalan Salamat
NPI 1669737243
$5,358.96
in general payments reported to CMS, 2019-2025
23 companies · $2,365 in 2025
The $2,365 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $39.18 · 2021: $881 · 2022: $382 · 2023: $586 · 2024: $907 · 2025: $2,365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,747 · Travel and Lodging: $1,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,747.26 |
| Travel and Lodging | $1,111.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $1,444.04 | 2019-2025 | Savi Scout |
| Medtronic, INC. | $1,009.41 | 2021-2025 | Plasmablade(Tm) |
| Stryker Corporation | $961.02 | 2025 | 1788, Molli |
| Biom'Up France Sas | $383.25 | 2021 | |
| Molli Surgical (US) INC | $359.89 | 2023-2024 | |
| Abbvie INC. | $260.76 | 2023-2024 | Alloderm, Natrelle Saline-Filled Breast Implants |
| Genentech USA, INC. | $237.97 | 2019-2021 | |
| Tactile Systems Technology INC | $173.60 | 2020-2021 | |
| Smith+Nephew, INC. | $135.17 | 2023 | Pico |
| Celgene Corporation | $81.84 | 2022 | |
| Epizyme, INC. | $66.58 | 2021 | |
| Davol INC. | $43.26 | 2024 | Phasix Mesh |
| Incyte Corporation | $27.11 | 2022 | |
| Amgen INC. | $26.27 | 2022 | |
| Sobi, INC | $24.00 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Morphosys, US INC. | $18.17 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $17.01 | 2022 | |
| Merck Sharp & Dohme LLC | $16.01 | 2022 | |
| Octapharma USA, INC. | $15.88 | 2022 | |
| Emd Serono, INC. | $15.47 | 2022 | |
| Seagen INC. | $15.22 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.36 | 2022 | |
| Leica Microsystems INC. | $12.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arsalan Salamat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.